论文部分内容阅读
过去非毒性甲状腺肿(NTG)传统的治疗方法是甲状腺制剂抑制或外科手术切除,但前者疗效不确切,后者有较大的风险,两者均有较高的复发率。近年来,采用~(131)Ⅰ口服治疗 NTG 逐渐增多,与前两种方法相比,具有安全、简便、疗效好、副作用较少的特点。本科自1998年6月～2004年3月采用~(131)Ⅰ治疗 NTG 患者共计107例,本研究总结了其中随访资料较完整的82例进行统计学分析,观察治疗后近期反应、疗效、并发症等,以期对本治疗方法作出一个较为客观的综合评价。
In the past, the traditional treatment for non-toxic goiter (NTG) was thyroid preparation suppression or surgical resection. However, the former had a poor response and the latter had a higher risk. Both had a high recurrence rate. In recent years, the use of ~ (131) Ⅰ oral treatment of NTG gradually increased, compared with the first two methods, with safety, simplicity, efficacy, fewer side effects. A total of 107 patients with NTG were treated with ~ (131) Ⅰ from June 1998 to March 2004. The data of 82 patients with complete follow-up were summarized and the short-term response, curative effect and concurrent Disease, etc., in order to make a more objective and comprehensive evaluation of the treatment.